Takashi Yoshinaga

Diversity-oriented synthesis yields novel multistage antimalarial inhibitors

Nobutaka Kato, Eamon Comer, Tomoyo Sakata‐Kato et al. · Nature · 2016 · 266 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes

Hiroyuki Ando, Takashi Yoshinaga, Wataru Yamamoto et al. · Journal of Pharmacological and Toxicological Methods · 2016 · 183 citations · Full text

Medicine, Pharmacology, Cellular Pharmacology +13

Differential nociceptive responses in mice lacking the α1B subunit of N-type Ca2+ channels

Shinji Hatakeyama, Minoru Wakamori, Mitsuhiro Ino et al. · Neuroreport · 2001 · 153 citations

Life Sciences, Neurobiology, Neuroscience +17

Functional disorders of the sympathetic nervous system in mice lacking the α _1B subunit (Ca _v 2.2) of N-type calcium channels

Mitsuhiro Ino, Takashi Yoshinaga, Minoru Wakamori et al. · Proceedings of the National Academy of Sciences · 2001 · 142 citations · Full text

Life Sciences, Neuroscience, Physiology +17

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA <i>In Silico</i> Strategy

Zhihua Li, Gary R. Mirams, Takashi Yoshinaga et al. · Clinical Pharmacology & Therapeutics · 2019 · 116 citations · Full text

Pharmacy, Cardiology, Pharmacology +9